Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2016

Mar 2, 2016

29777_dirs_2016-03-02_0768c696-44ac-4a60-9d9a-1e50333c3067.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2016-02-29

Reporting Person: Warmuth Michael J (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-02-29 Common shares without par value A 24033 Acquired 69217 Direct
2016-02-29 Common shares without par value F 4807 $39.52 Disposed 64410 Direct
2016-02-29 Common shares without par value S 2799 $38.841 Disposed 61611 Direct
2016-02-29 Common shares without par value S 6600 $38.845 Disposed 55011 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 29586 Indirect

Footnotes

F1: Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.

F2: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.